VANCOUVER, BC and MESA, AZ, Aug. 22, 2013 /PRNewswire/ - Avidus Management Group Inc. ("Avidus" or the "Company") (TSX-V: AVD, OTC: ASNHF) announced today that Asantae, its wholly owned subsidiary, has successfully recruited Erik Cloud to lead Asantae's network marketing related initiatives. Hailing from Boise, Idaho, Mr. Cloud has been a full-time networking professional for 15 years and is a proven public speaker, teacher and trainer. During his successful networking marketing career, he has been mentored by some of the preeminent networking professionals and has built sales organizations that number in the tens of thousands. He brings geographic diversity for Asantae with key distributor groups in the Pacific Northwest. Mr. Cloud was a leading author and played a vital role in the development of the Fast Track Business Building system. Avidus also announced that it will begin selling its network marketing tools and sales aids through a newly created division, Fast Track Systems. "Creating a division to sell its business tools represents an important step for Avidus in achieving its mission to provide standardized business building systems for its related companies," said Avidus President, Doug Ridley. The tools are based upon business building methods that have long been acknowledged throughout the industry as the gold standard. The first tools to be introduced are a uniform business presentation for recruiting, a standardized methodology to launch a new distributor's business supported by a comprehensive training manual to assist distributors with developing long-term success through duplication. About Avidus Avidus Management Group Inc. ( www.asantae.com) (TSX-V: AVD, OTC: ASNHF) through its wholly owned subsidiary, Asantae, develops, produces and markets innovative nutritional products through direct and network marketing channels. The ingredients in Asantae's products have been shown to reduce chronic low-grade inflammation and oxidative stress, and support a healthy immune system that, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (diabetes, heart disease, obesity, stroke, etc.). This news release may contain forward-looking statements relating to the Company's operations or to the environment in which it operates. Such statements are based on operations, estimates, forecasts and projections. They are not guarantees of future performance and involve risks and uncertainties that are difficult to predict and may be beyond the Company's control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements, including those set forth in the Company's regulatory filings. In addition, such statements relate to the date on which they are made and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, save and except as may be required by applicable securities laws.